Community Health Workers Led Integrated Management of Hypertension and Diabetes in Nepal

Recruiting N/A Interventional Study
Hypertension (HTN) Diabetes (DM)
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
30 and older
Sex
Any
Study type
Interventional
Purpose
Health Services Research
Participants needed
398 (estimated)
Sponsor
Kathmandu University School of Medical Sciences · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Hypertension (HTN) and diabetes mellitus are significant global public health challenges, contributing to 13.5% of premature deaths, 54% of incident strokes, and 47% of coronary heart disease cases (HTN), and increasing risks of cardiovascular diseases, kidney failure, and other complications (diabetes). In Nepal, HTN prevalence is 24.5% and diabetes affects 5.8% of adults (2019 Nepal STEPS Survey…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * 30 years or older * have a high blood pressure of 140/90 mmHg or under hypertension medication * have a high blood sugar of 6.5% or more (hba1c) or under diabetes medication are able to provide informed consent Exclusion Criteria: * any form of disabilities limiting particip…
Contacts

Archana Shrestha, PhD

9801002245

archana@kusms.edu.np

CONTACT

Bihungum Bista, MPH

9845537861

bistabihungum@gmail.com

CONTACT